STOCK TITAN

Wave Life Sciences to Present at the Third Annual Stifel CNS Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE) announced that CEO Paul Bolno and CMO Michael Panzara will participate in a virtual fireside chat at the Third Annual Stifel CNS Day on April 1, 2021, at 11:30 a.m. ET. Investors can access the presentation live via the company's investor relations page, with a replay available for 90 days afterward. Wave Life Sciences focuses on developing genetic medicines through its proprietary PRISM platform, targeting a range of genetically defined diseases.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., March 19, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer and Michael Panzara, MD, MPH, Chief Medical Officer and Head of Therapeutics Discovery and Development are scheduled to participate virtually in an analyst-led fireside chat at the Third Annual Stifel CNS Day on Wednesday, April 1, 2021 at 11:30 a.m. ET.

A live webcast of the presentation will be available on the investor relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com 


FAQ

What is Wave Life Sciences participating in on April 1, 2021?

Wave Life Sciences will participate in the Third Annual Stifel CNS Day.

Who are the speakers at the Wave Life Sciences event on April 1, 2021?

Paul Bolno, CEO, and Michael Panzara, CMO.

Where can I watch the Wave Life Sciences presentation on April 1, 2021?

The presentation will be available on the Wave Life Sciences investor relations page.

How long will the Wave Life Sciences presentation be available for replay?

The replay will be available for 90 days after the event.

What is Wave Life Sciences focused on developing?

Wave Life Sciences is focused on developing genetic medicines for genetically defined diseases.

Wave Life Sciences Ltd. Ordinary Shares

NASDAQ:WVE

WVE Rankings

WVE Latest News

WVE Stock Data

2.16B
129.41M
15.04%
78.49%
4.48%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SINGAPORE